Parallel neuroinflammatory pathways to cerebrovascular injury and amyloid-beta in Alzheimer's disease
Batool Rizvi,Jenna N Adams,Alison Bamford,Soyun Kim,Mithra Sathishkumar,Nicholas J. Tustison,Lisa Taylor,Nandita Tuteja,Liv McMillan,Bin Nan,Hengrui Cai,Yuritza Y Escalante,Novelle Meza,Alyssa L. Harris,Rond Malhas,Adam M. Brickman,Mark Mapstone,Elizabeth A. Thomas,Michael A Yassa
DOI: https://doi.org/10.1101/2024.10.03.616579
2024-10-04
Abstract:Importance: While the hallmark pathologies of amyloid-beta and tau in Alzheimer's disease (AD) are well documented and even part of the definition, upstream neuroinflammation is thought to play an important role but remains poorly understood. Objectives: We tested whether two distinct neuroinflammatory markers are associated with cerebrovascular injury and amyloid-beta, and whether these markers are associated with plasma phosphorylated tau (pTau) concentration, medial temporal lobe (MTL) cortical and hippocampal atrophy, and memory deficits. We examined neuroinflammatory markers plasma YKL-40 and GFAP, due to previous conflicting evidence relating YKL-40 and GFAP to AD pathogenic markers. Design: Cross-sectional data from a community observational study (Biomarker Exploration in Aging, Cognition, and Neurodegeneration - BEACoN) were included. Setting: All participants were enrolled in a single site, at University of California, Irvine. Participants: 126 participants were included if they had at least one of the following measures available: neuropsychological data, MRI, amyloid-PET, or plasma. Exposures: Plasma YKL-40 and plasma glial fibrillary acidic protein (GFAP) levels. Main outcomes and measures: White matter hyperintensity (WMH) volume, 18F-florbetapir (FBP) PET mean SUVR, plasma phosphorylated tau (pTau-217) concentration, MTL cortical thickness, hippocampal volume, and memory function assessed by Rey Auditory Verbal Learning Test. Using path analysis, we tested whether higher plasma YKL-40 and GFAP are associated with WMH and amyloid-beta, and whether these converge to downstream markers of tauopathy, MTL neurodegeneration, and memory deficits. Results: In older adults without dementia (N=126, age=70.60+6.29, 62% women), we found that higher plasma YKL-40 concentration was associated with greater WMH volume, while higher plasma GFAP concentration was related to increased FBP SUVR. Further, higher plasma GFAP, WMH and FBP SUVR were independently associated with increased pTau-217. In turn, plasma pTau-217 was associated with reduced MTL cortical thickness and hippocampal volume. Subsequently, only reduced hippocampal volume was related to lower memory function. Conclusions and Relevance: Neuroinflammatory markers contribute to parallel pathways of cerebrovascular injury and amyloid-beta, which converge to tau-associated neurodegeneration and memory deficits in older adults. These observations underscore the need for a more comprehensive approach to developing an AD framework and treatment strategies.
Neuroscience